logo
episode-header-image
Aug 2024
52m 35s

Lilly Is Selling Zepbound Vials at 50% D...

bloomberg
About this episode

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg News Health Care Reporter Madison Muller discusses Eli Lilly selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots. Silvio Tavares, CEO of VantageScore, provides the firm's credit data gauge of consumers. Bloomberg Businessweek Senior Editor Bret Begun shares stories from the Businessweek Magazine package on sports gambling. Ian Rogers, Chief Experience Officer at Ledger, talks about providing digital asset security for consumers and enterprises. And we Drive to the Close with Emily Roland, Co-Chief Investment Strategist at John Hancock Investment Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.

Up next
Nov 22
Bloomberg Businessweek Weekend - November 21st, 2025
<p>Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."<br>Hosted by Carol Massar and Tim Stenovec<br><br>Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. ... Show More
1h 16m
Nov 21
Trump Says He’d ‘Feel Very Comfortable’ Living in Mamdani’s NYC
<p>Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.<br><br>President Donald Trump said he wants to see Zohran Mamdani succeed, saying after a highly anticipated sit-down that he&rsquo;d &ldquo;feel very comfortable&rdquo; l ... Show More
37m 48s
Nov 21
Biomechatronics Pioneer on Meeting the Needs of Women Patients
<p>Hugh Herr is a driving force behind the creation of bionic limbs that emulate the function of natural limbs. His revolutionary work is in the emerging field of "Biomechatronics," a technology that marries human physiology with electromechanics. A double amputee himself, he is ... Show More
8m 38s
Recommended Episodes
Nov 2024
915. News: LATAM fintech is booming, Metrobank slapped with a hefty fine, and why Klarna chose NYC for its IPO
Join hosts Laura Watkins and Benjamin Ensor alongside some great guests as we look at the biggest financial services and fintech stories of the past week. Topics covered include: a LATAM fintech roundup featuring news from Nubank, Ualá, and Tako; Klarna announcing plans to IPO i ... Show More
1h 7m
Aug 2024
Zuckerberg Admits Censorship, Pavel Durov Arrested, RFK Jr. Endorses Trump | PBD Podcast | Ep. 463
<p>Patrick Bet-David, Adam Sosnick, Tom Ellsworth, and Amy Dangerfield cover Mark Zuckerberg admitting Meta censored COVID-19 information due to pressure from the Biden administration, the New York Times criticizing Kamala Harris' "Joy" campaign strategy, and Telegram CEO Pavel D ... Show More
2h 21m
Jul 2020
Big Tech – Big Profits, Busiest Week of Earnings Season Wraps Up, Questioning Kodak
<p>Carl Quintanilla, Jim Cramer and David Faber breakdown the blowout results from big tech. Apple posting a blowout third quarter, sales were up 11%, the tech giant also announcing a 4-for-1 stock split. Plus, hear what Apple CEO Tim Cook told Cramer. Amazon sales soaring, troun ... Show More
45m 14s
Jan 2025
932. Insights: How Zilch CEO Philip Belamant built a profitable fintech with over 4.5M customers
On this week's insights show, we're taking a deep dive into one of the most interesting fintech success stories in recent years - Zilch! Host Kate Moody is joined by Zilch Co-Founder and CEO Philip Belamant to discuss how the company went from raising its Series A funding during ... Show More
48m 25s
Feb 2025
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues. (00:21) Jason Moser and Matt Argersinger discuss: - How Nvidia continues to deliver in the face of great expectations, but even those great results haven’t kept the market happy with the chipmaker or big tech stocks to start ... Show More
40m 31s
Feb 2025
Ben & Jerry’s founders eye a second scoop
Ben & Jerry in talks to buy back eponymous brand from Unilever (UL). (00:30) Anheuser-Busch (BUD) sees only a limited impact on beer prices from tariffs in 2025. (02:05) META said to apologize for glitch that flooded Instagram Reels with graphic content. (02:56) Episode transcrip ... Show More
6m 28s
Oct 10
💄 “The Carrie Bradshaw Index” — Where to Live Solo. Amazon’s Prime Day retirement. Pizza by the Slice. +Jack’s Nvidia Poem.
<p>Amazon was sued for fake deals on Prime Day… it’s time to retire Prime Day.</p><p>Where can Americans afford to live solo in 2025?... Introducing The Carrie Bradshaw Index.</p><p>Restaurants are opening pizza shop side hustles… because pizza by the slice is a profit puppy.</p> ... Show More
22m 5s
Nov 10
1013. News: Big moves in the mortgage market - and is everyone using AI to manage their finances?
About this episode: Host Benjamin Ensor, Director of Research and Strategy at 11:FS, is joined by a fantastic panel of guests as we dive into some of the biggest stories from the worlds of fintech, banking, and wider financial services this week. Stories covered on the podcast th ... Show More
1h 3m
Sep 12
The man who made a billion off blueberries
Want to start your own million dollar business with less than $1k? Get the guide: https://clickhubspot.com/ejn Episode 744: Sam Parr ( https://x.com/theSamParr ) and Shaan Puri ( https://x.com/ShaanVP ) talk about the insane economics of Broadway shows, the blueberry billionaire ... Show More
1h 18m
Sep 29
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
<p>(0:00) Introducing Eli Lilly CEO Dave Ricks</p> <p>(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China</p> <p>(7:08) GLP-1 pricing and capital allocation after a breakout pharma product</p> <p>(12:56) Why Biotech VC has plummeted, " ... Show More
30m 40s